ESCI

Impact Factor

Hepatic Medicine: Evidence and Research

• Article Publishing Charges
• Aims and Scope
• Call For Papers

• View all (212)
• Volume 18, 2026 (2)
• Volume 17, 2025 (15)
• Volume 16, 2024 (10)
• Volume 15, 2023 (22)
• Volume 14, 2022 (13)
• Volume 13, 2021 (16)
• Volume 12, 2020 (16)
• Volume 11, 2019 (16)
• Volume 10, 2018 (13)
• Volume 9, 2017 (10)
• Volume 8, 2016 (15)
• Volume 7, 2015 (8)
• Volume 6, 2014 (12)
• Volume 5, 2013 (7)
• Volume 4, 2012 (7)
• Volume 3, 2011 (14)
• Volume 2, 2010 (14)
• Volume 1, 2009 (2)

Archive: Volume 1, 2009

Original Research

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors

M Gabrovska, F Geurs, S Ponette, et al

Hepatic Medicine: Evidence and Research 2009, 1:9-12

Published Date: 30 October 2009

Original Research

A high prevalence of extreme hyperferritinemia in acute hepatitis patients

Kazuhiro Kotoh, Akihiro Ueda, Masatake Tanaka, et al.

Hepatic Medicine: Evidence and Research 2009, 1:1-7

Published Date: 14 September 2009